Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1423891
                    [Title] => Metronidazole may raise inflammatory bowel disease risk
                    [Summary] => 
Exposure to antibiotics other than penicillins, in particular metronidazole and quinolones, was associated with new-onset Crohn’s disease, based on a meta-analysis of observational and case control studies presented at a conference on inflammatory bowel disease.

                    [DatePublished] => 2015-02-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 588186
                    [Title] => You have nothing to lose but your LBM
                    [Summary] => 
Diarrhea, or loose bowel movement (LBM), is a common ailment that millions of Filipinos have experienced at one point or another.
                    [DatePublished] => 2010-06-29 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 303194
                    [Title] => The young and the resolute:  Two 20-somethings cope with IBD
                    [Summary] => Patient X was accustomed to his daily stomachaches. They had been "just a part of his life" for as long as he could remember. But when he began to see blood in his stool and lost a good deal of weight, he knew something was seriously wrong. Patient X underwent a colonoscopy and a few weeks later learned that he had ulcerative colitis. For patient X at age 25, it was somewhat of a shock. He had stomach problems from the time he was a child, but wasn’t officially diagnosed with ulcerative colitis until he was 22.
                    [DatePublished] => 2005-10-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 267989
                    [Title] => Changing technologies benefit IBD sufferers
                    [Summary] => Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have there been "tremendous changes in the last three to five years," we can also expect great changes in the near future. Doctor calls this a "very optimistic time" for the diagnosis and treatment of IBD. So what’s on the horizon for those who suffer from Crohn’s disease and ulcerative colitis?
                    [DatePublished] => 2005-01-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 267647
                    [Title] => Evidence mounts for gut worm therapy
                    [Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy. 


In addition, in an open-label study of 29 patients with refractory Crohn’s disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission. 

                    [DatePublished] => 2005-01-02 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 232424
                    [Title] => Benefits of oatbran?
                    [Summary] => Could a daily bowl of oatmeal lessen symptoms of inflammatory bowel disease in the colon? Researchers are exploring this theory as they delve into studies on butyrate, a short chain fatty acid (SCFA) found in oatbran, and its effect on the cells lining the colon (colonocytes). 


                    [DatePublished] => 2003-12-21 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

IBD

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1423891
                    [Title] => Metronidazole may raise inflammatory bowel disease risk
                    [Summary] => 
Exposure to antibiotics other than penicillins, in particular metronidazole and quinolones, was associated with new-onset Crohn’s disease, based on a meta-analysis of observational and case control studies presented at a conference on inflammatory bowel disease.

                    [DatePublished] => 2015-02-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 588186
                    [Title] => You have nothing to lose but your LBM
                    [Summary] => 
Diarrhea, or loose bowel movement (LBM), is a common ailment that millions of Filipinos have experienced at one point or another.
                    [DatePublished] => 2010-06-29 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 303194
                    [Title] => The young and the resolute:  Two 20-somethings cope with IBD
                    [Summary] => Patient X was accustomed to his daily stomachaches. They had been "just a part of his life" for as long as he could remember. But when he began to see blood in his stool and lost a good deal of weight, he knew something was seriously wrong. Patient X underwent a colonoscopy and a few weeks later learned that he had ulcerative colitis. For patient X at age 25, it was somewhat of a shock. He had stomach problems from the time he was a child, but wasn’t officially diagnosed with ulcerative colitis until he was 22.
                    [DatePublished] => 2005-10-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 267989
                    [Title] => Changing technologies benefit IBD sufferers
                    [Summary] => Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have there been "tremendous changes in the last three to five years," we can also expect great changes in the near future. Doctor calls this a "very optimistic time" for the diagnosis and treatment of IBD. So what’s on the horizon for those who suffer from Crohn’s disease and ulcerative colitis?
                    [DatePublished] => 2005-01-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 267647
                    [Title] => Evidence mounts for gut worm therapy
                    [Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy. 


In addition, in an open-label study of 29 patients with refractory Crohn’s disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission. 

                    [DatePublished] => 2005-01-02 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 232424
                    [Title] => Benefits of oatbran?
                    [Summary] => Could a daily bowl of oatmeal lessen symptoms of inflammatory bowel disease in the colon? Researchers are exploring this theory as they delve into studies on butyrate, a short chain fatty acid (SCFA) found in oatbran, and its effect on the cells lining the colon (colonocytes). 


                    [DatePublished] => 2003-12-21 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Metronidazole may raise inflammatory bowel disease risk

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | February 15, 2015 - 12:00am

Exposure to antibiotics other than penicillins, in particular metronidazole and quinolones, was associated with new-onset Crohn’s disease, based on a meta-analysis of observational and case control studies...

Opinion

You have nothing to lose but your LBM

June 29, 2010 - 12:00am

Diarrhea, or loose bowel movement (LBM), is a common ailment that millions of Filipinos have experienced at one point or another.

Health And Family

The young and the resolute: Two 20-somethings cope with IBD

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 23, 2005 - 12:00am

Patient X was accustomed to his daily stomachaches. They had been "just a part of his life" for as long as he could remember. But when he began to see blood in his stool and lost a good deal of weight,...

Opinion

Changing technologies benefit IBD sufferers

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 30, 2005 - 12:00am

Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have...

Opinion

Evidence mounts for gut worm therapy

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 2, 2005 - 12:00am

Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind,...

Opinion

Benefits of oatbran?

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 21, 2003 - 12:00am

Could a daily bowl of oatmeal lessen symptoms of inflammatory bowel disease in the colon? Researchers are exploring this theory as they delve into studies on butyrate, a short chain fatty acid (SCFA) found in oatbran,...

Opinion